JPS5634670A - Oxoimidazolinealkanoic acid derivative* its manufacture and pharmaceutic composition - Google Patents

Oxoimidazolinealkanoic acid derivative* its manufacture and pharmaceutic composition

Info

Publication number
JPS5634670A
JPS5634670A JP11716480A JP11716480A JPS5634670A JP S5634670 A JPS5634670 A JP S5634670A JP 11716480 A JP11716480 A JP 11716480A JP 11716480 A JP11716480 A JP 11716480A JP S5634670 A JPS5634670 A JP S5634670A
Authority
JP
Japan
Prior art keywords
oxoimidazolinealkanoic
manufacture
acid derivative
pharmaceutic composition
pharmaceutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11716480A
Other languages
English (en)
Inventor
Haineru Roitenshiyureege Hansu
Betsuchingu Hansu
Sutooru Burijitsuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Natterman und Cie GmbH
Original Assignee
A Natterman und Cie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Natterman und Cie GmbH filed Critical A Natterman und Cie GmbH
Publication of JPS5634670A publication Critical patent/JPS5634670A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/38—One oxygen atom attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP11716480A 1979-08-28 1980-08-27 Oxoimidazolinealkanoic acid derivative* its manufacture and pharmaceutic composition Pending JPS5634670A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792934746 DE2934746A1 (de) 1979-08-28 1979-08-28 Oxoimidazolinalkansaeuren, deren salze und ester sowie verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
JPS5634670A true JPS5634670A (en) 1981-04-06

Family

ID=6079489

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11716480A Pending JPS5634670A (en) 1979-08-28 1980-08-27 Oxoimidazolinealkanoic acid derivative* its manufacture and pharmaceutic composition

Country Status (6)

Country Link
US (1) US4330550A (ja)
JP (1) JPS5634670A (ja)
DE (1) DE2934746A1 (ja)
FR (1) FR2464254A1 (ja)
GB (1) GB2057427B (ja)
IT (1) IT1131936B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3042466A1 (de) * 1980-11-11 1982-06-16 A. Nattermann & Cie GmbH, 5000 Köln N-substituierte (omega) -(2-oxo-4-imidazolin-l-yl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3228271A1 (de) * 1982-07-29 1984-02-02 A. Nattermann & Cie GmbH, 5000 Köln Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4845233A (en) * 1987-09-11 1989-07-04 Iprx, Inc. Imidazolin-2-ones
CA2036192A1 (en) 1990-02-13 1991-08-14 Nicholas Meanwell Heterocyclic carboxylic acids and esters
US4970225A (en) * 1990-02-13 1990-11-13 Bristol-Myers Squibb Company Imidazolidine carboxylic acids and esters as blood platelet aggregation inhibitors
FR2711653B1 (fr) * 1993-10-27 1996-01-05 Atochem Elf Sa Procédé de préparation de (méth)acrylates d'alkylimidazolidone.
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2430006A (en) * 1944-04-29 1947-11-04 Hoffmann La Roche 4-methyl-5-imidazolone-(2)-caproic acid and esters thereof
US2492373A (en) * 1946-01-25 1949-12-27 John L Wood Imidazolone preparation
US4090025A (en) * 1976-04-26 1978-05-16 American Cyanamid Company Intermediates for synthesis of tetramisole, levamisole and their derivatives

Also Published As

Publication number Publication date
DE2934746A1 (de) 1981-03-19
IT8023340A0 (it) 1980-07-09
FR2464254A1 (fr) 1981-03-06
GB2057427B (en) 1983-05-18
IT1131936B (it) 1986-06-25
US4330550A (en) 1982-05-18
GB2057427A (en) 1981-04-01

Similar Documents

Publication Publication Date Title
PT71744B (en) Substituted beta-carbolin-3-carboxylic acid derivatives
JPS55105674A (en) Quanidine derivative*its manufacture and pharmaceutic composition containing antihistamic
GB2043644B (en) 3-phosphonocephalosporanic acid derivatives process for preparation thereof and pharmaceutical composition comprising the same
GB2117774B (en) Oximinoacetic acid derivatives
JPS5634670A (en) Oxoimidazolinealkanoic acid derivative* its manufacture and pharmaceutic composition
JPS562960A (en) Pyrrolidinylalkylcarboxylic acid amide derivative* its manufacture and medicinal composition
NZ194784A (en) 7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
JPS5535074A (en) Nnphenylindoline derivative*its manufacture and pharmaceutic composition containing it
NZ193005A (en) Phenyl-azolyl-acrylic acid derivatives and fungicidal compositions
JPS5677225A (en) Pharmaceutic composition
AU533471B2 (en) Pharmaceutical composition comprising modified polyriboinosinic-polyribocytidylic acid
ZA806383B (en) Long acting pharmaceutical composition
PH14049A (en) 9-aminodeoxyclavulanic acid compound and pharmaceutical composition
JPS56108790A (en) Novel pyrrolobenzotriazepines*their manufacture and pharmaceutic composition containing them
JPS56100718A (en) Pharmaceutic composition
JPS5463031A (en) Propanethio acid derivative and its composition
JPS5683485A (en) 77oxoopgi2 derivative* its manufacture and pharmaceutic composition containing it
NZ194122A (en) Acylaminobenzoic acid derivatives and pharmaceutical compositions
PH16046A (en) Dihydronicotinic acid derivatives and their compositions
JPS5557591A (en) Cluvalanic acid derivative*its manufacture and composition
IL61751A0 (en) Acylamino-3-cepham-4-carboxylic acid derivatives,their manufacture and pharmalceutical compositions containing them
ZA803734B (en) Acylaminobenzoic acid derivatives
JPS5520792A (en) Clavaranic acid derivative*its manufacture and composition
JPS568363A (en) Indoline derivative* its manufacture and pharmaceutic composition containing same
JPS5455593A (en) Curavaric acid derivative * production thereof and composition